Covid: Straus (Ema), ‘3 rare cases of thrombosis out of 4.5 million vaccinated with J&J’

Milan, April 7 (beraking latest news Health) – “3 cases” of rare and abnormal thrombosis have been reported with the Johnson & Johnson anti-Covid vaccine after the marketing of the shield product “out of 4.5 million vaccinated”. This was reported by Sabine Straus, head of the Prac Pharmacovigilance Committee of the European drug agency EMA, answering a question about the rare cases of abnormal blood clots observed after vaccination. The expert talked about it today during the press conference where she took stock of the risk of these very rare events – cases of CVST (cerebral sinus thrombosis) and abdominal splanchnic vein thrombosis, associated with low levels of pastrine – for the AstraZeneca vaccine, after the evaluations of the Prac.

“We also have 35 cases of cerebral thrombosis of the venous sinuses Cvst for Comirnaty”, the anti-Covid vaccine from Pfizer and BioNTech, “out of 54 million” vaccinated, Straus still listed, “and for Moderna 5 cases out of 4 million vaccinations “.